Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?
KIM-1 U concentrations may predict cisplatin-induced AKI in early stages with high sensitivity and specificity.
MMP9 appears to be regulated at the transcript level, whereas MMP2 is regulated at the posttranscriptional level. Poor survival with a high frequency of metastases in 'conventional' RCC is associated with MMP9, which exhibits a high transcriptional level, and a high gelatinolytic activity. As a result, MMP9 may be a candidate of predictors of disease-free survival in RCC.